# Filing Detail

Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-23-000348
Filing Date
2023-01-06
Accepted
2023-01-06 16:54:42
Documents
9

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B5 | gern010623.htm | 424B5 | 1869333
2 | EX-FILING FEES | gern-exfiling_fees.htm | EX-FILING FEES | 37158
3 | GRAPHIC | img175210594_0.jpg | GRAPHIC | 4766
4 | GRAPHIC | img175210594_1.jpg | GRAPHIC | 576509
5 | GRAPHIC | img175210594_2.jpg | GRAPHIC | 384053
6 | GRAPHIC | img175210594_3.jpg | GRAPHIC | 545898
7 | GRAPHIC | img175210594_4.jpg | GRAPHIC | 429184
8 | GRAPHIC | img175210594_5.jpg | GRAPHIC | 537906
9 | GRAPHIC | img175210594_6.jpg | GRAPHIC | 3209
| Complete submission text file | 0000950170-23-000348.txt |  | 5324252

Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-269111 | Film No.: 23515675
SIC: 2834 Pharmaceutical Preparations